OCRELIZUMAB

45470 reported adverse events

Drug classes: CD20-directed Cytolytic Antibody [EPC]

These side effects are most commonly reported by patients taking OCRELIZUMAB:

# Side effect Count
0 COVID-19 9836
1 FATIGUE 4639
2 URINARY TRACT INFECTION 3097
3 HEADACHE 2450
4 MULTIPLE SCLEROSIS RELAPSE 2189
5 MULTIPLE SCLEROSIS 2150
6 ASTHENIA 2103
7 GAIT DISTURBANCE 2044
8 NASOPHARYNGITIS 2001
9 FALL 1941
See all common reactions for OCRELIZUMAB

OCRELIZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SARS-COV-2 ANTIBODY TEST NEGATIVE 227 0.5942
1 JC POLYOMAVIRUS TEST POSITIVE 441 0.4667
2 RELAPSING MULTIPLE SCLEROSIS 99 0.3852
3 B-LYMPHOCYTE COUNT DECREASED 340 0.3527
4 B-LYMPHOCYTE COUNT INCREASED 52 0.3312
5 MULTIPLE SCLEROSIS PSEUDO RELAPSE 49 0.2634
6 MAGNETIC RESONANCE IMAGING ABNORMAL 162 0.1954
7 BLOOD IMMUNOGLOBULIN M DECREASED 101 0.1391
8 CYSTITIS NONINFECTIVE 139 0.1260
9 SARS-COV-2 TEST POSITIVE 1275 0.1104
See all enriched reactions for OCRELIZUMAB